世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

トロンボエラストグラフィ（TEG）装置産業調査レポート 2023年


Thromboelastography (TEG) Machine Industry Research Report 2023

当レポートは、血栓破砕（TEG）装置の世界市場を量的・質的分析の両面から包括的に提示することで、読者がビジネス/成長戦略を策定し、市場競争状況を評価し、現在の市場における自社のポジションを分析し、血栓... もっと見る

　

　

出版社 出版年月 電子版価格 ページ数 図表数 言語
APO Research
エーピーオーリサーチ 		2023年8月11日 US$2,950
シングルユーザライセンス
ライセンス・価格情報
注文方法はこちら 		100 146 英語

日本語のページは自動翻訳を利用し作成しています。


　

サマリー

当レポートは、血栓破砕（TEG）装置の世界市場を量的・質的分析の両面から包括的に提示することで、読者がビジネス/成長戦略を策定し、市場競争状況を評価し、現在の市場における自社のポジションを分析し、血栓破砕（TEG）装置に関する十分な情報に基づいたビジネス上の意思決定を行えるようにすることを目的としています。
血栓乳房造影（TEG）装置の市場規模、推計、予測は、2022年を基準年として、2018年から2029年までの期間の履歴データと予測データを考慮し、販売台数（単位）と収益（百万ドル）で提供します。本レポートでは、世界の血栓弾性線維造影（TEG）装置市場を包括的に区分しています。種類別、用途別、プレイヤー別の製品に関する地域別市場規模も掲載しています。COVID-19とロシア・ウクライナ戦争の影響は市場規模を推定する際に考慮した。
市場のより詳細な理解のために、本レポートは競合状況、主要競合企業のプロフィール、それぞれの市場ランクを提供している。また、技術動向や新製品開発についても論じています。
本レポートは、企業別、製品タイプ別、用途別、地域別に、市場全体とサブセグメント全体の収益、販売量、平均価格に関する情報を提供し、本市場における血栓弾性線維造影（TEG）装置メーカー、新規参入企業、産業チェーン関連企業の一助となることでしょう。
主要企業と市場シェアの洞察
このセクションでは、読者は競合する主要企業について理解を深めることができる。本レポートでは、革新的な動向や開発、製品ポートフォリオの強化、M&A、提携、新製品の革新、地理的拡大など、参入企業が存在感を維持するために行っている主要な成長戦略を調査している。事業戦略の他に、本調査には現在の開発状況や主要財務情報も含まれている。読者はまた、2018年から2023年までのメーカー別の世界的な収益、価格、売上高に関連するデータにアクセスすることができます。この包括的なレポートは、クライアントが最新情報を入手し、ビジネスにおいて効果的な意思決定を行うために確実に役立つだろう。調査レポートでレビューされた著名なプレーヤーは以下の通りです：
Haemonetics
レプ・テクノロジー
バイオマート
メドキャプテン
ウドバイオ
重慶南方
WITEYE
レンダー
貴州錦江生物科技
重慶ディンルン
浙江神宇
バイオジルコン
ヴェルフェンライフ
Framar Hemologix srl
シエンコ
製品タイプ別インサイト
世界市場を血栓破砕（TEG）装置のタイプ別に、2029年までの成長予測とともに掲載しています。売上高と収益の推計は、血栓乳房造影（TEG）装置がメーカーによって調達されるサプライチェーンにおける価格に基づいています。
本レポートは各セグメントを調査し、過去のデータを用いて市場規模を提供しています。また、そのセグメントが将来もたらす成長機会についても触れています。この調査は、タイプ別、過去期間（2018-2023）と予測期間（2024-2029）の売上高と収益データを提供します。
トロンボエラストグラフィ（TEG）装置のタイプ別セグメント
シングルチャンネルとダブルチャンネル
4チャンネル
その他
アプリケーションインサイト
本レポートでは、過去期間（2018-2023年）および予測期間（2024-2029年）におけるアプリケーション別の市場規模（売上高および収益データ）を掲載しています。
また、血栓破砕（TEG）装置市場に影響を与える各セグメントの市場動向や消費者行動について概説し、これらが業界の将来にどのような影響を及ぼす可能性があるかについても記載しています。本レポートは、血栓乳房造影（TEG）装置市場を牽引している関連市場および消費者動向の把握に役立ちます。
血栓乳房造影（TEG）装置の用途別セグメント
病院
母子保健サービス
研究所
その他
地域別展望
本セクションでは、様々な地域と各地域で事業を展開する主要企業に関する主要な洞察を提供する。経済、社会、環境、技術、政治的要因が、特定の地域／国の成長を評価する際に考慮されている。読者は、2018年から2029年までの各地域・国の収益・売上データも手にすることができる。
市場は、北米、欧州、アジア太平洋、南米、中東＆アフリカを含む様々な主要地域に区分されている。米国、ドイツ、英国、イタリア、フランス、中国、日本、韓国、東南アジア、インドなどの主要国の詳細な分析は、地域セグメント内でカバーされます。市場推計については、2021年を基準年として、2023年の推計値、2029年の予測収益を提供する予定である。
北米
米国
カナダ
欧州
ドイツ
フランス
英国
イタリア
ロシア
アジア太平洋
中国
日本
韓国
インド
オーストラリア
中国 台湾
インドネシア
タイ
マレーシア
ラテンアメリカ
メキシコ
ブラジル
アルゼンチン
中東・アフリカ
トルコ
サウジアラビア
アラブ首長国連邦
主な推進要因と障壁
本レポートでは、読者が一般的な発展を理解するのに役立つよう、影響力の大きいレンダリング要因とドライバーを調査している。さらに、プレイヤーの行く手を阻む阻害要因や課題も含まれています。これは、ユーザーが気を配り、ビジネスに関連する情報に基づいた意思決定を行うのに役立ちます。また、専門家は今後のビジネス展望にも焦点を当てている。
COVID-19とロシア・ウクライナ戦争の影響力分析
このセクションの読者は、パンデミック、パンデミック後、ロシア-ウクライナ戦争中に血栓拡張（TEG）装置市場のシナリオが世界中でどのように変化したかを理解することができます。この調査は、需要、消費、輸送、消費者行動、サプライチェーン管理、輸出入、生産などの側面の変化を視野に入れて行われています。また、業界の専門家は、今後数年間、プレーヤーに機会を創出し、業界全体を安定させるのに役立つ主要因を強調しています。
本レポートを購入する理由
本レポートは、読者が潜在的な利益を高めるために、業界内の競争と競争環境の戦略を理解するのに役立ちます。また、世界の血栓破砕（TEG）装置市場の競争環境に焦点を当て、主要企業の市場シェア、業界ランキング、競合エコシステム、市場実績、新製品開発、経営状況、事業拡大、買収などを詳細に紹介し、読者が主要な競合企業を特定し、市場の競争パターンを深く理解するのに役立ちます。
本レポートは、関係者が血栓弾性線維造影（TEG）装置の世界的な産業状況と動向を理解するのに役立ち、主要な市場促進要因、阻害要因、課題、機会に関する情報を提供します。
本レポートは、利害関係者が競合他社をよりよく理解し、事業における地位を強化するためのより多くの洞察を得るのに役立ちます。競争環境のセクションには、市場シェアと順位（数量と金額）、競合他社のエコシステム、新製品開発、拡大、買収が含まれます。
本レポートは、斬新な技術統合、機能、市場の最新動向を常に更新しています。
本レポートは、利害関係者がCOVID-19およびロシア・ウクライナ戦争が血栓弾性線維造影（TEG）装置産業に及ぼす影響を理解するのに役立ちます。
本レポートは、利害関係者が世界的にどの地域をターゲットとすべきかについて洞察するのに役立ちます。
本レポートは、関係者が血栓拡張（TEG）装置の採用に関するエンドユーザーの認識について洞察するのに役立ちます。
本レポートは、利害関係者が市場の主要プレイヤーを特定し、その価値ある貢献を理解するのに役立ちます。
コアチャプター
第1章：調査目的、調査方法、データソース、データの相互検証
第2章： レポートのスコープ、各市場セグメント（地域別、製品タイプ別、用途別など）の市場規模、今後の発展可能性などのエグゼクティブサマリーを紹介。市場の現状と短期・中期・長期的な展開の可能性について高いレベルの見解を提供しています。
第3章 血栓塞栓造影（TEG）装置メーカーの競争環境、価格、生産量、市場シェア、最新の開発計画、合併・買収情報などを詳細に分析。
第4章：主要企業のプロファイルを提供し、製品の生産/生産量、価値、価格、粗利益率、製品紹介、最近の開発など、市場の主要企業の基本的な状況を詳細に紹介する。
第5章 血栓塞栓造影（TEG）装置の地域別/国別生産/生産量、金額。今後6年間の各地域の市場規模と発展の可能性を定量的に分析しています。
第6章 血栓塞栓造影（TEG）装置の地域別・国別消費量各地域とその主要国の市場規模と発展可能性を定量的に分析し、世界各国の市場発展、将来発展展望、市場空間、生産量などを紹介しています。
第7章：様々な市場セグメントを種類別に分析し、各市場セグメントの市場規模と発展可能性を網羅し、読者が様々な市場セグメントにおけるブルーオーシャン市場を見つけるのに役立つ。
第8章：用途別の様々な市場セグメントの分析を提供し、各市場セグメントの市場規模と発展可能性をカバーし、読者が異なる下流市場のブルーオーシャン市場を見つけるのを助ける。
第9章：産業の上流と下流を含む産業チェーンの分析。
第10章：市場力学、市場の最新動向、市場の推進要因と制限要因、業界のメーカーが直面する課題とリスク、業界の関連政策の分析を紹介する。
第11章：レポートの要点と結論。


ページTOPに戻る


目次

1 Preface
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 Market Overview
2.1 Product Definition
2.2 Global Market Growth Prospects
2.2.1 Global Thromboelastography (TEG) Machine Market Size (2018-2029) & (US$ Million)
2.2.2 Global Thromboelastography (TEG) Machine Sales (2018-2029)
2.2.3 Global Thromboelastography (TEG) Machine Market Average Price (2018-2029)
2.3 Thromboelastography (TEG) Machine by Type
2.3.1 Market Value Comparison by Type (2018 VS 2022 VS 2029) & (US$ Million)
1.2.2 Single and Double Channel
1.2.3 Four Channels
1.2.4 Others
2.4 Thromboelastography (TEG) Machine by Application
2.4.1 Market Value Comparison by Application (2018 VS 2022 VS 2029) & (US$ Million)
2.4.2 Hospitals
2.4.3 Maternal and Child Health Service
2.4.4 Laboratory
2.4.5 Others
3 Market Competitive Landscape by Manufacturers
3.1 Global Thromboelastography (TEG) Machine Market Competitive Situation by Manufacturers (2018 Versus 2022)
3.2 Global Thromboelastography (TEG) Machine Sales (Units) of Manufacturers (2018-2023)
3.3 Global Thromboelastography (TEG) Machine Revenue of Manufacturers (2018-2023)
3.4 Global Thromboelastography (TEG) Machine Average Price by Manufacturers (2018-2023)
3.5 Global Thromboelastography (TEG) Machine Industry Ranking, 2021 VS 2022 VS 2023
3.6 Global Manufacturers of Thromboelastography (TEG) Machine, Manufacturing Sites & Headquarters
3.7 Global Manufacturers of Thromboelastography (TEG) Machine, Product Type & Application
3.8 Global Manufacturers of Thromboelastography (TEG) Machine, Date of Enter into This Industry
3.9 Global Thromboelastography (TEG) Machine Market CR5 and HHI
3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
4.1 Haemonetics
4.1.1 Haemonetics Company Information
4.1.2 Haemonetics Business Overview
4.1.3 Haemonetics Thromboelastography (TEG) Machine Sales, Revenue and Gross Margin (2018-2023)
4.1.4 Haemonetics Thromboelastography (TEG) Machine Product Portfolio
4.1.5 Haemonetics Recent Developments
4.2 Lepu Technology
4.2.1 Lepu Technology Company Information
4.2.2 Lepu Technology Business Overview
4.2.3 Lepu Technology Thromboelastography (TEG) Machine Sales, Revenue and Gross Margin (2018-2023)
4.2.4 Lepu Technology Thromboelastography (TEG) Machine Product Portfolio
4.2.5 Lepu Technology Recent Developments
4.3 Biomart
4.3.1 Biomart Company Information
4.3.2 Biomart Business Overview
4.3.3 Biomart Thromboelastography (TEG) Machine Sales, Revenue and Gross Margin (2018-2023)
4.3.4 Biomart Thromboelastography (TEG) Machine Product Portfolio
4.3.5 Biomart Recent Developments
4.4 Medcaptain
4.4.1 Medcaptain Company Information
4.4.2 Medcaptain Business Overview
4.4.3 Medcaptain Thromboelastography (TEG) Machine Sales, Revenue and Gross Margin (2018-2023)
4.4.4 Medcaptain Thromboelastography (TEG) Machine Product Portfolio
4.4.5 Medcaptain Recent Developments
4.5 Ud-bio
4.5.1 Ud-bio Company Information
4.5.2 Ud-bio Business Overview
4.5.3 Ud-bio Thromboelastography (TEG) Machine Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Ud-bio Thromboelastography (TEG) Machine Product Portfolio
6.5.5 Ud-bio Recent Developments
4.6 Chongqing Nanfang
4.6.1 Chongqing Nanfang Company Information
4.6.2 Chongqing Nanfang Business Overview
4.6.3 Chongqing Nanfang Thromboelastography (TEG) Machine Sales, Revenue and Gross Margin (2018-2023)
4.6.4 Chongqing Nanfang Thromboelastography (TEG) Machine Product Portfolio
4.6.5 Chongqing Nanfang Recent Developments
4.7 WITEYE
4.7.1 WITEYE Company Information
4.7.2 WITEYE Business Overview
4.7.3 WITEYE Thromboelastography (TEG) Machine Sales, Revenue and Gross Margin (2018-2023)
4.7.4 WITEYE Thromboelastography (TEG) Machine Product Portfolio
4.7.5 WITEYE Recent Developments
6.8 Render
4.8.1 Render Company Information
4.8.2 Render Business Overview
4.8.3 Render Thromboelastography (TEG) Machine Sales, Revenue and Gross Margin (2018-2023)
4.8.4 Render Thromboelastography (TEG) Machine Product Portfolio
4.8.5 Render Recent Developments
4.9 Guizhou Jinjiu Biotech
4.9.1 Guizhou Jinjiu Biotech Company Information
4.9.2 Guizhou Jinjiu Biotech Business Overview
4.9.3 Guizhou Jinjiu Biotech Thromboelastography (TEG) Machine Sales, Revenue and Gross Margin (2018-2023)
4.9.4 Guizhou Jinjiu Biotech Thromboelastography (TEG) Machine Product Portfolio
4.9.5 Guizhou Jinjiu Biotech Recent Developments
4.10 Chongqing Dingrun
4.10.1 Chongqing Dingrun Company Information
4.10.2 Chongqing Dingrun Business Overview
4.10.3 Chongqing Dingrun Thromboelastography (TEG) Machine Sales, Revenue and Gross Margin (2018-2023)
4.10.4 Chongqing Dingrun Thromboelastography (TEG) Machine Product Portfolio
4.10.5 Chongqing Dingrun Recent Developments
6.11 Zhejiang Shengyu
6.11.1 Zhejiang Shengyu Company Information
6.11.2 Zhejiang Shengyu Thromboelastography (TEG) Machine Business Overview
6.11.3 Zhejiang Shengyu Thromboelastography (TEG) Machine Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Zhejiang Shengyu Thromboelastography (TEG) Machine Product Portfolio
6.11.5 Zhejiang Shengyu Recent Developments
6.12 Bio-zircon
6.12.1 Bio-zircon Company Information
6.12.2 Bio-zircon Thromboelastography (TEG) Machine Business Overview
6.12.3 Bio-zircon Thromboelastography (TEG) Machine Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Bio-zircon Thromboelastography (TEG) Machine Product Portfolio
6.12.5 Bio-zircon Recent Developments
6.13 WerfenLife
6.13.1 WerfenLife Company Information
6.13.2 WerfenLife Thromboelastography (TEG) Machine Business Overview
6.13.3 WerfenLife Thromboelastography (TEG) Machine Sales, Revenue and Gross Margin (2018-2023)
6.13.4 WerfenLife Thromboelastography (TEG) Machine Product Portfolio
6.13.5 WerfenLife Recent Developments
6.14 Framar Hemologix srl
6.14.1 Framar Hemologix srl Company Information
6.14.2 Framar Hemologix srl Thromboelastography (TEG) Machine Business Overview
6.14.3 Framar Hemologix srl Thromboelastography (TEG) Machine Sales, Revenue and Gross Margin (2018-2023)
6.14.4 Framar Hemologix srl Thromboelastography (TEG) Machine Product Portfolio
6.14.5 Framar Hemologix srl Recent Developments
6.15 Sienco
6.15.1 Sienco Company Information
6.15.2 Sienco Thromboelastography (TEG) Machine Business Overview
6.15.3 Sienco Thromboelastography (TEG) Machine Sales, Revenue and Gross Margin (2018-2023)
6.15.4 Sienco Thromboelastography (TEG) Machine Product Portfolio
6.15.5 Sienco Recent Developments
5 Global Thromboelastography (TEG) Machine Market Scenario by Region
5.1 Global Thromboelastography (TEG) Machine Market Size by Region: 2018 VS 2022 VS 2029
5.2 Global Thromboelastography (TEG) Machine Sales by Region: 2018-2029
5.2.1 Global Thromboelastography (TEG) Machine Sales by Region: 2018-2023
5.2.2 Global Thromboelastography (TEG) Machine Sales by Region: 2024-2029
5.3 Global Thromboelastography (TEG) Machine Revenue by Region: 2018-2029
5.3.1 Global Thromboelastography (TEG) Machine Revenue by Region: 2018-2023
5.3.2 Global Thromboelastography (TEG) Machine Revenue by Region: 2024-2029
5.4 North America Thromboelastography (TEG) Machine Market Facts & Figures by Country
5.4.1 North America Thromboelastography (TEG) Machine Market Size by Country: 2018 VS 2022 VS 2029
5.4.2 North America Thromboelastography (TEG) Machine Sales by Country (2018-2029)
5.4.3 North America Thromboelastography (TEG) Machine Revenue by Country (2018-2029)
5.4.4 United States
5.4.5 Canada
5.5 Europe Thromboelastography (TEG) Machine Market Facts & Figures by Country
5.5.1 Europe Thromboelastography (TEG) Machine Market Size by Country: 2018 VS 2022 VS 2029
5.5.2 Europe Thromboelastography (TEG) Machine Sales by Country (2018-2029)
5.5.3 Europe Thromboelastography (TEG) Machine Revenue by Country (2018-2029)
5.5.4 Germany
5.5.5 France
5.5.6 U.K.
5.5.7 Italy
5.5.8 Russia
5.6 Asia Pacific Thromboelastography (TEG) Machine Market Facts & Figures by Country
5.6.1 Asia Pacific Thromboelastography (TEG) Machine Market Size by Country: 2018 VS 2022 VS 2029
5.6.2 Asia Pacific Thromboelastography (TEG) Machine Sales by Country (2018-2029)
5.6.3 Asia Pacific Thromboelastography (TEG) Machine Revenue by Country (2018-2029)
5.6.4 China
5.6.5 Japan
5.6.6 South Korea
5.6.7 India
5.6.8 Australia
5.6.9 China Taiwan
5.6.10 Indonesia
5.6.11 Thailand
5.6.12 Malaysia
5.7 Latin America Thromboelastography (TEG) Machine Market Facts & Figures by Country
5.7.1 Latin America Thromboelastography (TEG) Machine Market Size by Country: 2018 VS 2022 VS 2029
5.7.2 Latin America Thromboelastography (TEG) Machine Sales by Country (2018-2029)
5.7.3 Latin America Thromboelastography (TEG) Machine Revenue by Country (2018-2029)
5.7.4 Mexico
5.7.5 Brazil
5.7.6 Argentina
5.8 Middle East and Africa Thromboelastography (TEG) Machine Market Facts & Figures by Country
5.8.1 Middle East and Africa Thromboelastography (TEG) Machine Market Size by Country: 2018 VS 2022 VS 2029
5.8.2 Middle East and Africa Thromboelastography (TEG) Machine Sales by Country (2018-2029)
5.8.3 Middle East and Africa Thromboelastography (TEG) Machine Revenue by Country (2018-2029)
5.8.4 Turkey
5.8.5 Saudi Arabia
5.8.6 UAE
6 Segment by Type
6.1 Global Thromboelastography (TEG) Machine Sales by Type (2018-2029)
6.1.1 Global Thromboelastography (TEG) Machine Sales by Type (2018-2029) & (Units)
6.1.2 Global Thromboelastography (TEG) Machine Sales Market Share by Type (2018-2029)
6.2 Global Thromboelastography (TEG) Machine Revenue by Type (2018-2029)
6.2.1 Global Thromboelastography (TEG) Machine Sales by Type (2018-2029) & (US$ Million)
6.2.2 Global Thromboelastography (TEG) Machine Revenue Market Share by Type (2018-2029)
6.3 Global Thromboelastography (TEG) Machine Price by Type (2018-2029)
7 Segment by Application
7.1 Global Thromboelastography (TEG) Machine Sales by Application (2018-2029)
7.1.1 Global Thromboelastography (TEG) Machine Sales by Application (2018-2029) & (Units)
7.1.2 Global Thromboelastography (TEG) Machine Sales Market Share by Application (2018-2029)
7.2 Global Thromboelastography (TEG) Machine Revenue by Application (2018-2029)
6.2.1 Global Thromboelastography (TEG) Machine Sales by Application (2018-2029) & (US$ Million)
6.2.2 Global Thromboelastography (TEG) Machine Revenue Market Share by Application (2018-2029)
7.3 Global Thromboelastography (TEG) Machine Price by Application (2018-2029)
8 Value Chain and Sales Channels Analysis of the Market
8.1 Thromboelastography (TEG) Machine Value Chain Analysis
8.1.1 Thromboelastography (TEG) Machine Key Raw Materials
8.1.2 Raw Materials Key Suppliers
8.1.3 Thromboelastography (TEG) Machine Production Mode & Process
8.2 Thromboelastography (TEG) Machine Sales Channels Analysis
8.2.1 Direct Comparison with Distribution Share
8.2.2 Thromboelastography (TEG) Machine Distributors
8.2.3 Thromboelastography (TEG) Machine Customers
9 Global Thromboelastography (TEG) Machine Analyzing Market Dynamics
9.1 Thromboelastography (TEG) Machine Industry Trends
9.2 Thromboelastography (TEG) Machine Industry Drivers
9.3 Thromboelastography (TEG) Machine Industry Opportunities and Challenges
9.4 Thromboelastography (TEG) Machine Industry Restraints
10 Report Conclusion
11 Disclaimer

　

ページTOPに戻る


　

Summary

This report aims to provide a comprehensive presentation of the global market for Thromboelastography (TEG) Machine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Thromboelastography (TEG) Machine.
The Thromboelastography (TEG) Machine market size, estimations, and forecasts are provided in terms of sales volume (Units) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Thromboelastography (TEG) Machine market comprehensively. Regional market sizes, concerning products by types, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Thromboelastography (TEG) Machine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2018-2023. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
Haemonetics
Lepu Technology
Biomart
Medcaptain
Ud-bio
Chongqing Nanfang
WITEYE
Render
Guizhou Jinjiu Biotech
Chongqing Dingrun
Zhejiang Shengyu
Bio-zircon
WerfenLife
Framar Hemologix srl
Sienco
Product Type Insights
Global markets are presented by Thromboelastography (TEG) Machine type, along with growth forecasts through 2029. Estimates on sales and revenue are based on the price in the supply chain at which the Thromboelastography (TEG) Machine are procured by the manufacturers.
This report has studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows sales and revenue data by type, and during the historical period (2018-2023) and forecast period (2024-2029).
Thromboelastography (TEG) Machine segment by Type
Single and Double Channel
Four Channels
Others
Application Insights
This report has provided the market size (sales and revenue data) by application, during the historical period (2018-2023) and forecast period (2024-2029).
This report also outlines the market trends of each segment and consumer behaviors impacting the Thromboelastography (TEG) Machine market and what implications these may have on the industry's future. This report can help to understand the relevant market and consumer trends that are driving the Thromboelastography (TEG) Machine market.
Thromboelastography (TEG) Machine segment by Application
Hospitals
Maternal and Child Health Service
Laboratory
Others
Regional Outlook
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue and sales data of each region and country for the period 2018-2029.
The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, South America, Middle East & Africa. Detailed analysis of major countries such as the USA, Germany, the U.K., Italy, France, China, Japan, South Korea, Southeast Asia, and India will be covered within the regional segment. For market estimates, data are going to be provided for 2021 because of the base year, with estimates for 2023 and forecast revenue for 2029.
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Thromboelastography (TEG) Machine market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Reasons to Buy This Report
This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Thromboelastography (TEG) Machine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
This report will help stakeholders to understand the global industry status and trends of Thromboelastography (TEG) Machine and provides them with information on key market drivers, restraints, challenges, and opportunities.
This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
This report stays updated with novel technology integration, features, and the latest developments in the market
This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the Thromboelastography (TEG) Machine industry.
This report helps stakeholders to gain insights into which regions to target globally
This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Thromboelastography (TEG) Machine.
This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Core Chapters
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Thromboelastography (TEG) Machine manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Thromboelastography (TEG) Machine by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Thromboelastography (TEG) Machine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.



ページTOPに戻る


Table of Contents

1 Preface
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 Market Overview
2.1 Product Definition
2.2 Global Market Growth Prospects
2.2.1 Global Thromboelastography (TEG) Machine Market Size (2018-2029) & (US$ Million)
2.2.2 Global Thromboelastography (TEG) Machine Sales (2018-2029)
2.2.3 Global Thromboelastography (TEG) Machine Market Average Price (2018-2029)
2.3 Thromboelastography (TEG) Machine by Type
2.3.1 Market Value Comparison by Type (2018 VS 2022 VS 2029) & (US$ Million)
1.2.2 Single and Double Channel
1.2.3 Four Channels
1.2.4 Others
2.4 Thromboelastography (TEG) Machine by Application
2.4.1 Market Value Comparison by Application (2018 VS 2022 VS 2029) & (US$ Million)
2.4.2 Hospitals
2.4.3 Maternal and Child Health Service
2.4.4 Laboratory
2.4.5 Others
3 Market Competitive Landscape by Manufacturers
3.1 Global Thromboelastography (TEG) Machine Market Competitive Situation by Manufacturers (2018 Versus 2022)
3.2 Global Thromboelastography (TEG) Machine Sales (Units) of Manufacturers (2018-2023)
3.3 Global Thromboelastography (TEG) Machine Revenue of Manufacturers (2018-2023)
3.4 Global Thromboelastography (TEG) Machine Average Price by Manufacturers (2018-2023)
3.5 Global Thromboelastography (TEG) Machine Industry Ranking, 2021 VS 2022 VS 2023
3.6 Global Manufacturers of Thromboelastography (TEG) Machine, Manufacturing Sites & Headquarters
3.7 Global Manufacturers of Thromboelastography (TEG) Machine, Product Type & Application
3.8 Global Manufacturers of Thromboelastography (TEG) Machine, Date of Enter into This Industry
3.9 Global Thromboelastography (TEG) Machine Market CR5 and HHI
3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
4.1 Haemonetics
4.1.1 Haemonetics Company Information
4.1.2 Haemonetics Business Overview
4.1.3 Haemonetics Thromboelastography (TEG) Machine Sales, Revenue and Gross Margin (2018-2023)
4.1.4 Haemonetics Thromboelastography (TEG) Machine Product Portfolio
4.1.5 Haemonetics Recent Developments
4.2 Lepu Technology
4.2.1 Lepu Technology Company Information
4.2.2 Lepu Technology Business Overview
4.2.3 Lepu Technology Thromboelastography (TEG) Machine Sales, Revenue and Gross Margin (2018-2023)
4.2.4 Lepu Technology Thromboelastography (TEG) Machine Product Portfolio
4.2.5 Lepu Technology Recent Developments
4.3 Biomart
4.3.1 Biomart Company Information
4.3.2 Biomart Business Overview
4.3.3 Biomart Thromboelastography (TEG) Machine Sales, Revenue and Gross Margin (2018-2023)
4.3.4 Biomart Thromboelastography (TEG) Machine Product Portfolio
4.3.5 Biomart Recent Developments
4.4 Medcaptain
4.4.1 Medcaptain Company Information
4.4.2 Medcaptain Business Overview
4.4.3 Medcaptain Thromboelastography (TEG) Machine Sales, Revenue and Gross Margin (2018-2023)
4.4.4 Medcaptain Thromboelastography (TEG) Machine Product Portfolio
4.4.5 Medcaptain Recent Developments
4.5 Ud-bio
4.5.1 Ud-bio Company Information
4.5.2 Ud-bio Business Overview
4.5.3 Ud-bio Thromboelastography (TEG) Machine Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Ud-bio Thromboelastography (TEG) Machine Product Portfolio
6.5.5 Ud-bio Recent Developments
4.6 Chongqing Nanfang
4.6.1 Chongqing Nanfang Company Information
4.6.2 Chongqing Nanfang Business Overview
4.6.3 Chongqing Nanfang Thromboelastography (TEG) Machine Sales, Revenue and Gross Margin (2018-2023)
4.6.4 Chongqing Nanfang Thromboelastography (TEG) Machine Product Portfolio
4.6.5 Chongqing Nanfang Recent Developments
4.7 WITEYE
4.7.1 WITEYE Company Information
4.7.2 WITEYE Business Overview
4.7.3 WITEYE Thromboelastography (TEG) Machine Sales, Revenue and Gross Margin (2018-2023)
4.7.4 WITEYE Thromboelastography (TEG) Machine Product Portfolio
4.7.5 WITEYE Recent Developments
6.8 Render
4.8.1 Render Company Information
4.8.2 Render Business Overview
4.8.3 Render Thromboelastography (TEG) Machine Sales, Revenue and Gross Margin (2018-2023)
4.8.4 Render Thromboelastography (TEG) Machine Product Portfolio
4.8.5 Render Recent Developments
4.9 Guizhou Jinjiu Biotech
4.9.1 Guizhou Jinjiu Biotech Company Information
4.9.2 Guizhou Jinjiu Biotech Business Overview
4.9.3 Guizhou Jinjiu Biotech Thromboelastography (TEG) Machine Sales, Revenue and Gross Margin (2018-2023)
4.9.4 Guizhou Jinjiu Biotech Thromboelastography (TEG) Machine Product Portfolio
4.9.5 Guizhou Jinjiu Biotech Recent Developments
4.10 Chongqing Dingrun
4.10.1 Chongqing Dingrun Company Information
4.10.2 Chongqing Dingrun Business Overview
4.10.3 Chongqing Dingrun Thromboelastography (TEG) Machine Sales, Revenue and Gross Margin (2018-2023)
4.10.4 Chongqing Dingrun Thromboelastography (TEG) Machine Product Portfolio
4.10.5 Chongqing Dingrun Recent Developments
6.11 Zhejiang Shengyu
6.11.1 Zhejiang Shengyu Company Information
6.11.2 Zhejiang Shengyu Thromboelastography (TEG) Machine Business Overview
6.11.3 Zhejiang Shengyu Thromboelastography (TEG) Machine Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Zhejiang Shengyu Thromboelastography (TEG) Machine Product Portfolio
6.11.5 Zhejiang Shengyu Recent Developments
6.12 Bio-zircon
6.12.1 Bio-zircon Company Information
6.12.2 Bio-zircon Thromboelastography (TEG) Machine Business Overview
6.12.3 Bio-zircon Thromboelastography (TEG) Machine Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Bio-zircon Thromboelastography (TEG) Machine Product Portfolio
6.12.5 Bio-zircon Recent Developments
6.13 WerfenLife
6.13.1 WerfenLife Company Information
6.13.2 WerfenLife Thromboelastography (TEG) Machine Business Overview
6.13.3 WerfenLife Thromboelastography (TEG) Machine Sales, Revenue and Gross Margin (2018-2023)
6.13.4 WerfenLife Thromboelastography (TEG) Machine Product Portfolio
6.13.5 WerfenLife Recent Developments
6.14 Framar Hemologix srl
6.14.1 Framar Hemologix srl Company Information
6.14.2 Framar Hemologix srl Thromboelastography (TEG) Machine Business Overview
6.14.3 Framar Hemologix srl Thromboelastography (TEG) Machine Sales, Revenue and Gross Margin (2018-2023)
6.14.4 Framar Hemologix srl Thromboelastography (TEG) Machine Product Portfolio
6.14.5 Framar Hemologix srl Recent Developments
6.15 Sienco
6.15.1 Sienco Company Information
6.15.2 Sienco Thromboelastography (TEG) Machine Business Overview
6.15.3 Sienco Thromboelastography (TEG) Machine Sales, Revenue and Gross Margin (2018-2023)
6.15.4 Sienco Thromboelastography (TEG) Machine Product Portfolio
6.15.5 Sienco Recent Developments
5 Global Thromboelastography (TEG) Machine Market Scenario by Region
5.1 Global Thromboelastography (TEG) Machine Market Size by Region: 2018 VS 2022 VS 2029
5.2 Global Thromboelastography (TEG) Machine Sales by Region: 2018-2029
5.2.1 Global Thromboelastography (TEG) Machine Sales by Region: 2018-2023
5.2.2 Global Thromboelastography (TEG) Machine Sales by Region: 2024-2029
5.3 Global Thromboelastography (TEG) Machine Revenue by Region: 2018-2029
5.3.1 Global Thromboelastography (TEG) Machine Revenue by Region: 2018-2023
5.3.2 Global Thromboelastography (TEG) Machine Revenue by Region: 2024-2029
5.4 North America Thromboelastography (TEG) Machine Market Facts & Figures by Country
5.4.1 North America Thromboelastography (TEG) Machine Market Size by Country: 2018 VS 2022 VS 2029
5.4.2 North America Thromboelastography (TEG) Machine Sales by Country (2018-2029)
5.4.3 North America Thromboelastography (TEG) Machine Revenue by Country (2018-2029)
5.4.4 United States
5.4.5 Canada
5.5 Europe Thromboelastography (TEG) Machine Market Facts & Figures by Country
5.5.1 Europe Thromboelastography (TEG) Machine Market Size by Country: 2018 VS 2022 VS 2029
5.5.2 Europe Thromboelastography (TEG) Machine Sales by Country (2018-2029)
5.5.3 Europe Thromboelastography (TEG) Machine Revenue by Country (2018-2029)
5.5.4 Germany
5.5.5 France
5.5.6 U.K.
5.5.7 Italy
5.5.8 Russia
5.6 Asia Pacific Thromboelastography (TEG) Machine Market Facts & Figures by Country
5.6.1 Asia Pacific Thromboelastography (TEG) Machine Market Size by Country: 2018 VS 2022 VS 2029
5.6.2 Asia Pacific Thromboelastography (TEG) Machine Sales by Country (2018-2029)
5.6.3 Asia Pacific Thromboelastography (TEG) Machine Revenue by Country (2018-2029)
5.6.4 China
5.6.5 Japan
5.6.6 South Korea
5.6.7 India
5.6.8 Australia
5.6.9 China Taiwan
5.6.10 Indonesia
5.6.11 Thailand
5.6.12 Malaysia
5.7 Latin America Thromboelastography (TEG) Machine Market Facts & Figures by Country
5.7.1 Latin America Thromboelastography (TEG) Machine Market Size by Country: 2018 VS 2022 VS 2029
5.7.2 Latin America Thromboelastography (TEG) Machine Sales by Country (2018-2029)
5.7.3 Latin America Thromboelastography (TEG) Machine Revenue by Country (2018-2029)
5.7.4 Mexico
5.7.5 Brazil
5.7.6 Argentina
5.8 Middle East and Africa Thromboelastography (TEG) Machine Market Facts & Figures by Country
5.8.1 Middle East and Africa Thromboelastography (TEG) Machine Market Size by Country: 2018 VS 2022 VS 2029
5.8.2 Middle East and Africa Thromboelastography (TEG) Machine Sales by Country (2018-2029)
5.8.3 Middle East and Africa Thromboelastography (TEG) Machine Revenue by Country (2018-2029)
5.8.4 Turkey
5.8.5 Saudi Arabia
5.8.6 UAE
6 Segment by Type
6.1 Global Thromboelastography (TEG) Machine Sales by Type (2018-2029)
6.1.1 Global Thromboelastography (TEG) Machine Sales by Type (2018-2029) & (Units)
6.1.2 Global Thromboelastography (TEG) Machine Sales Market Share by Type (2018-2029)
6.2 Global Thromboelastography (TEG) Machine Revenue by Type (2018-2029)
6.2.1 Global Thromboelastography (TEG) Machine Sales by Type (2018-2029) & (US$ Million)
6.2.2 Global Thromboelastography (TEG) Machine Revenue Market Share by Type (2018-2029)
6.3 Global Thromboelastography (TEG) Machine Price by Type (2018-2029)
7 Segment by Application
7.1 Global Thromboelastography (TEG) Machine Sales by Application (2018-2029)
7.1.1 Global Thromboelastography (TEG) Machine Sales by Application (2018-2029) & (Units)
7.1.2 Global Thromboelastography (TEG) Machine Sales Market Share by Application (2018-2029)
7.2 Global Thromboelastography (TEG) Machine Revenue by Application (2018-2029)
6.2.1 Global Thromboelastography (TEG) Machine Sales by Application (2018-2029) & (US$ Million)
6.2.2 Global Thromboelastography (TEG) Machine Revenue Market Share by Application (2018-2029)
7.3 Global Thromboelastography (TEG) Machine Price by Application (2018-2029)
8 Value Chain and Sales Channels Analysis of the Market
8.1 Thromboelastography (TEG) Machine Value Chain Analysis
8.1.1 Thromboelastography (TEG) Machine Key Raw Materials
8.1.2 Raw Materials Key Suppliers
8.1.3 Thromboelastography (TEG) Machine Production Mode & Process
8.2 Thromboelastography (TEG) Machine Sales Channels Analysis
8.2.1 Direct Comparison with Distribution Share
8.2.2 Thromboelastography (TEG) Machine Distributors
8.2.3 Thromboelastography (TEG) Machine Customers
9 Global Thromboelastography (TEG) Machine Analyzing Market Dynamics
9.1 Thromboelastography (TEG) Machine Industry Trends
9.2 Thromboelastography (TEG) Machine Industry Drivers
9.3 Thromboelastography (TEG) Machine Industry Opportunities and Challenges
9.4 Thromboelastography (TEG) Machine Industry Restraints
10 Report Conclusion
11 Disclaimer

　

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野の最新刊レポート

  • 本レポートと同分野の最新刊レポートはありません。

APO Research社のMedical Devices & Consumables分野での最新刊レポート

本レポートと同じKEY WORD（industry）の最新刊レポート

  • 本レポートと同じKEY WORDの最新刊レポートはありません。

よくあるご質問


APO Research社はどのような調査会社ですか?


 もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
お客様よりデータリソース社へ（通常は円払い）の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

お問合せはこちらから

03-3582-2531

電話お問合せもお気軽に

 

2024/11/22　10:26

155.52 円

163.34 円

198.56 円

ページTOPに戻る

株式会社 データリソース　Data Resources, Inc.
東京都港区赤坂1-14-5　アークヒルズエグゼクティブタワー N313

電話：03-3582-2531
FAX：03-3582-2861
Eメール：office@dri.co.jp

FAQ サイトマップ プライバシーポリシー お問合せ

関連会社:
株式会社ユーディーアール

COPYRIGHT(C) 2011-2023　DATA RESOURCES, Inc. ALL RIGHTS RESERVED.